Skip to main content
Login
Contact
Subscribe
Search form
Search
The Sweetwater Reporter
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Corbus Pharma
(NQ:
CRBP
)
6.890
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
4:00 AM EDT, Jun 5, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
40
Open
6.890
Bid (Size)
7.600 (3)
Ask (Size)
9.920 (2)
Prev. Close
6.890
Today's Range
6.890 - 6.890
52wk Range
3.290 - 8.660
Shares Outstanding
57,142,496
Dividend Yield
N/A
Performance
YTD
+27.59%
+27.59%
1 Month
+6.16%
+6.16%
3 Month
+48.17%
+48.17%
6 Month
+39.19%
+39.19%
1 Year
+1.92%
+1.92%
Top News
More News
Corbus Pharmaceuticals Announces Publication of Phase 2b Cystic Fibrosis Study Patient Demographics and Baseline Disease Characteristics in the Journal of Cystic Fibrosis
June 01, 2020
from
GlobeNewswire News Releases
Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
May 27, 2020
from
GlobeNewswire News Releases
More News
Read More
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress
May 22, 2020
from
GlobeNewswire News Releases
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 15, 2020
from
GlobeNewswire News Releases
Corbus Pharmaceuticals Reports First Quarter Financial Results and Corporate Updates
May 11, 2020
from
GlobeNewswire News Releases
Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
May 04, 2020
from
GlobeNewswire News Releases
Viela Bio Announces Election of Rachelle Jacques to its Board of Directors
April 30, 2020
from
GlobeNewswire News Releases
Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
April 29, 2020
from
GlobeNewswire News Releases
Noteworthy Thursday Option Activity: CRBP, UAL, CMTL
June 04, 2020
category
Stocks
from
Market News Video
Implied IWO Analyst Target Price: $230
May 26, 2020
category
ETFs
from
ETF Channel
Corbus Pharmaceuticals: Q1 Earnings Insights
May 11, 2020
category
News
,
CRBP
,
Market News
, and 2 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
